Er. Woodward et al., GENETIC PREDISPOSITION TO PHEOCHROMOCYTOMA - ANALYSIS OF CANDIDATE GENES GDNF, RET AND VHL, Human molecular genetics, 6(7), 1997, pp. 1051-1056
Inherited predisposition to phaeochromocytoma (MIM No 171300) occurs i
n multiple endocrine neoplasia type 2 (MEN 2) (MIM No 171400), von Hip
pel-Lindau (VHL) disease (MIM No 199300), and neurofibromatosis type 1
(NF1) (MIM No 162200), In addition, familial phaeochromocytoma alone
has also been reported and we and others have identified germline VHL
mutations in five of six kindreds analysed previously, Germline mutati
ons in the RET proto-oncogene, which encodes a receptor tyrosine kinas
e, and in the VHL tumour suppressor gene cause MEN 2 and VHL disease,
respectively, To further investigate the genetics of phaeochromocytoma
predisposition, we analysed three groups of patients with no evidence
of VHL disease, MEN 2 or NF1: Group A, eight kindreds with familial p
haeochromocytoma; Group B, two patients with isolated bilateral phaeoc
hromocytoma; and Group C, six cases of multiple extra-adrenal phaeochr
omocytoma or adrenal phaeochromocytoma with a family history of neuroe
ctodermal tumours, Germline missense VHL mutations were identified in
three of eight kindreds with familial phaeochromocytoma, A germline VH
L mutation was also characterised in one of the two patients with bila
teral phaeochromocytoma, No VHL or RET mutations were detected in the
final group of patients with multiple extra-adrenal phaeochromocytoma
or adrenal phaeochromocytoma with a family history of neuroectodermal
tumours, The absence of germline VHL and RET gene mutations in many of
these families suggested that other phaeochromocytoma susceptibility
loci may exist, Glial cell line-derived neurotrophic factor (GDNF) has
been recently identified as a natural ligand for RET Thus, it seems p
lausible that GDNF is a good candidate gene to play a role in phaeochr
omocytoma susceptibility, We searched for germline mutations in GDNF i
n 16 cases of familial phaeochromocytoma (groups A, B and C) and looke
d for evidence of somatic change in GDNF in 28 sporadic phaeochromocyt
omas, 12 MEN 2 phaeochromocytomas and five VHL phaeochromocytomas, No
GDNF mutations were identified in patients with familial phaeochromocy
toma disease, but a c277C-->T (R93W) sequence variant was identified i
n one of 28 sporadic tumours, This candidate mutation was identified i
n the germline and tumour tissue but was not present in 104 control GD
NF alleles, GDNF sequence variants including R93W have been suggested
previously to represent low penetrance susceptibility mutations for Hi
rschsprung disease and the R93W was not identified in 376 control alle
les studied by others, These findings suggest that although GDNF mutat
ions do not appear to have a major role in the pathogenesis of familia
l or sporadic phaeochromocytomas, allelic variation at the GDNF locus
may modify phaeochromocytoma susceptibility.